Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Released: September 11, 2018
To examine opportunities to improve cancer diagnosis and care, the National Cancer Policy Forum developed a two-workshop series. The first workshop—held on February 12-13, 2018 in , DC—focused on potential strategies to ensure patients have access to appropriate expertise and technologies in oncologic pathology and imaging to inform cancer diagnosis and subsequent care decisions.
Released: July 06, 2018
On March 6, 2018, the Forum on Neuroscience and Nervous System Disorders, in collaboration with the Committee on Science, Technology, and Law (CSTL), held a public workshop to explore and advance efforts to identify and evaluate the potential effects of emerging neurotechnologies on the legal system.
Released: June 29, 2018
An ad hoc committee planned a workshop exploring the evidence for special nutritional requirements in disease states and medical conditions that cannot be met with a normal diet.
Released: June 08, 2018
On December 12-13, the Forum on Microbial Threats, in collaboration with the Board on Life Sciences hosted a workshop examining "Urbanization and Slums: New Transmission Pathways of Infectious Diseases in the Built Environment."
Released: May 24, 2018
Delivering high-quality cancer care to all patients presents numerous challenges, including difficulties with ensuring patients have access to well-coordinated care across the cancer continuum. Patient navigation programs are designed to promote access to timely cancer diagnosis and care by addressing barriers to cancer care, such as challenges with health literacy, language barriers affecting comprehension of diagnosis and treatment, lack of transportation, or insufficient insurance coverage. Patient navigation programs were originally designed—and are still primarily directed at—improving cancer care among vulnerable patients.
Released: May 16, 2018
Those facing serious illness have a range of interconnected medical and non-medical needs, and the way their care is financed has a large impact on the care they receive. Medicare is the predominant payer, but both Medicaid and private payers also play significant roles in financing care for serious illness. In an effort to address the complex needs of people with serious illness, public and private health care payers are testing innovative financing strategies and alternative payment models.
Released: April 27, 2018
To examine progress in cancer survivorship care since the consensus report From Cancer Patient to Cancer Survivor: Lost in Transition, the National Cancer Policy Forum held a workshop, “Long-Term Survivorship Care After Cancer Treatment” on July 24 and July 25, 2017, in , DC. Workshop presentations and discussions highlighted potential opportunities to improve the planning, management, and delivery of cancer survivorship care.
Released: March 23, 2018
Chronic pain is one of the most prevalent, costly, and disabling health conditions in the United States. In parallel with increasing recognition of the need to treat chronic pain, the opioid epidemic has emerged as a growing public health emergency. In 2017, the National Institutes of Health began exploring public-private partnerships to develop solutions to the opioid crisis and cut in half the time it takes to develop non-addictive analgesics. To help inform this effort, the AffiliateMarketIngtools’ Forum on Neuroscience and Nervous Systems Disorders hosted a public workshop that brought together experts and stakeholders from academia, federal agencies, advocacy organizations, and companies developing therapeutics for pain and opioid use disorders.
Released: March 08, 2018
The blood-brain barrier (BBB) presents a special challenge to the development of therapeutics for many central nervous system (CNS) disorders. Far from acting simply as a physical barrier, the BBB is a complex dynamic system involving several cell types, passive and active transport mechanisms, and adaptive function to control the exchange of substances between the blood and the CNS. Few therapeutic agents readily traverse the BBB to reach the brain or spinal cord, including most small molecule drugs and the vast majority of large molecules such as proteins.
Released: December 08, 2017
To build on previous work, to explore developments since the last workshop was convened, and to help parlay knowledge into immediate action, an ad hoc planning committee, under the auspices of the Forum of Microbial Threats at the AffiliateMarketIngtools, planned a 2-day public workshop Combating Antimicrobial Resistance: A One Health Approach to a Global Threat. The workshop explored issues of antimicrobial resistance through the lens of One Health, which is a collaborative approach of multiple disciplines—working locally, nationally, and globally—for strengthening systems to counter infectious diseases and related issues that threaten human, animal, and environmental health, with an end point of improving global health and achieving gains in development.